Amyotrophic Lateral Sclerosis Risk Genes and Suppressor

Area of Science:

• Neurodegenerative diseases
• Genetics of ALS

Background:

• Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive paralysis and respiratory failure.
• Approximately 90-95% of ALS cases are sporadic (sALS), while 5-10% are familial (fALS).
• Around 40 genes are implicated in ALS, with mutations in SOD1, C9ORF72, FUS, and TDP-43 being major contributors.

Approach:

• This review focuses on identifying therapeutic targets for ALS.
• It examines crucial gene mutations and their associated cellular dysfunctions, including oxidative stress, excitotoxicity, protein aggregation, and mitochondrial dysfunction.
• The review highlights the potential of single pathway repair to restore multiple dysfunctional cellular pathways in ALS.

Key Points:

• Mutations in key genes like SOD1, C9ORF72, FUS, and TDP-43 lead to diverse cellular pathologies in ALS.
• Dysfunctional cellular pathways contribute significantly to ALS pathogenesis.
• Restoration of a single cellular pathway can potentially ameliorate multiple disease symptoms.

Conclusions:

• Identifying specific mutations and understanding their phenotypic suppressors are crucial for therapeutic development in ALS.
• Targeting single pathways offers a promising strategy to reduce the multifaceted symptoms of ALS.
• Further research into these pathways may lead to novel therapeutic interventions for this devastating disease.